Recombinant Formamidopyrimidine-DNA glycosylase (mutM)

Shipped with Ice Packs
In Stock

Description

Molecular Structure and Catalytic Mechanism

MutM is a bifunctional glycosylase/lyase enzyme with a conserved structure across bacteria. Key structural features include:

  • Zinc finger domain: Essential for DNA binding and damage recognition .

  • Active site residues: Lys-217 and Arg-108 are critical for substrate specificity, with Lys-217 interacting directly with 8-oxoG and Arg-108 determining opposite-base pairing preferences .

  • Helix-two-turn-helix (H2TH) motif: Facilitates DNA backbone cleavage after base excision .

The enzyme operates by flipping damaged bases out of the DNA helix, excising them via hydrolysis, and cleaving the DNA backbone through β,δ-elimination .

Recombinant Production and Purification

Recombinant MutM is typically expressed in Escherichia coli and purified using chromatographic techniques. Key specifications include:

PropertyDetails
Expression SystemE. coli with N-terminal His-tag
Molecular Weight32.4 kDa (269 amino acids)
Purity≥90% (SDS-PAGE)
Activity>20,000 units/mg protein; excises 8-oxoG, FapyG, and FapyA
Storage20 mM Tris-HCl (pH 8.0), 100 mM NaCl, 1 mM DTT, 20% glycerol

Substrate Specificity and Biochemical Activity

MutM targets a broad spectrum of oxidative lesions. Comparative activity data from E. coli and mycobacterial homologs:

SubstrateRelative Excision EfficiencyKey Residues Involved
8-oxoG:CHigh (Primary substrate) Lys-217, Arg-108
FapyGHigh His-89, Arg-109
Gh/Sp (Oxidation products)Moderate (Plant homologs show higher activity) Zinc finger domain
8-oxoG:ALow (Requires MutY for repair) N/A

Note: Gh = Guanidinohydantoin; Sp = Spiroiminohydantoin.

Mycobacterial MutM (e.g., Mtb-Fpg1) shows distinct mutagenic profiles compared to E. coli, with preferential G incorporation opposite 8-oxoG during replication, reducing C→A mutations .

Role in Oxidative DNA Repair Pathways

MutM is central to the "GO system," which includes MutY and MutT:

  1. MutM: Excises 8-oxoG from 8-oxoG:C pairs .

  2. MutY: Removes misincorporated A from 8-oxoG:A mismatches .

  3. MutT: Hydrolyzes 8-oxo-dGTP to prevent its incorporation into DNA .

In Mycobacterium smegmatis, MutM deficiency increases A→G mutations by 3-fold and sensitizes cells to hydrogen peroxide . Exposure to sublethal H₂O₂ shifts mutation profiles toward C→G transversions, highlighting context-dependent repair dynamics .

Antimutagenic Role

  • E. coli MutM suppresses GC→TA transversions by 20-fold in synergy with MutY .

  • Mycobacterial MutM deficiency elevates mutation rates by 5–12× under oxidative stress .

Biotechnological Use

  • Genomic analysis: Recombinant MutM is used to map oxidative DNA damage in sequencing studies .

  • Enzyme kinetics: Studies on MutM variants (e.g., K217A, R108A) elucidate damage recognition mechanisms .

Evolutionary and Pathogenic Implications

  • Mycobacteria: High genomic G+C content increases susceptibility to 8-oxoG accumulation, making MutM critical for survival in macrophages .

  • Tandem repeats upstream of *Mtb-fpg1*: Variable repeat lengths in Mycobacterium tuberculosis correlate with gene expression levels, influencing oxidative stress adaptation .

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have special format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult local distributors for specific delivery times. Proteins are shipped with blue ice packs by default. Request dry ice in advance for an extra fee.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you have a specific tag type requirement, please inform us.
Synonyms
mutM; fpg; Formamidopyrimidine-DNA glycosylase; Fapy-DNA glycosylase; EC 3.2.2.23; DNA-(apurinic or apyrimidinic site) lyase MutM; AP lyase MutM; EC 4.2.99.18
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
2-284
Protein Length
Full Length of Mature Protein
Purity
>85% (SDS-PAGE)
Species
Synechococcus elongatus
Target Names
mutM
Target Protein Sequence
PELPEVETV RRGLELVTLK QPIVDVEVLL ARSIALPKEP QAFIEHLRDR RIEQWQRRGK YLLATLDDGS RLVIHLRMSG QLLWLTTPQP PCPHTRVRWF FPTRAELRFV DQRTFGRCWW LPPDCRVAEA IPALATLAPE PLSEAFTVAF LAARLAHCRR SIKTALLDQS IVAGMGNIYA DESLFLSGLH PTQSAHTLTP EQVQRLHGVI CQVLREGIAA GGTTIRTFMS PAGVNGHYGG QAWVYGRKGE ACRVCGTTIE RLRLAGRSSH YCPQCQPLSS AIGK
Uniprot No.

Target Background

Function
Involved in base excision repair of DNA damaged by oxidation or mutagens. This DNA glycosylase recognizes and removes damaged bases, preferring oxidized purines like 8-oxoG. It has AP lyase activity, nicking DNA via beta-delta elimination at the removed base, leaving both 3' and 5' phosphates.
Protein Families
FPG family

Q&A

What is Formamidopyrimidine-DNA glycosylase (mutM) and what is its primary function?

Formamidopyrimidine-DNA glycosylase (mutM) is a primary enzyme involved in the base excision repair pathway, specifically targeting oxidative DNA lesions. It serves as a critical participant in the repair of 8-oxoguanine, which is an abundant oxidative DNA lesion . The enzyme functions by recognizing and excising damaged bases, creating an apurinic/apyrimidinic site that is subsequently processed by other components of the repair machinery. This activity is essential for maintaining genomic integrity by preventing the mutagenic effects of oxidative DNA damage.

How does mutM recognize damaged DNA bases?

MutM recognizes damaged DNA bases through a sophisticated structural mechanism involving specific amino acid residues. The enzyme contains a "reading head" structure that scans DNA for damage, with His-89 and Arg-109 forming part of this recognition apparatus . When potential damage is detected, the enzyme flips the damaged nucleotide into an extrahelical position and accommodates it within a binding pocket where Lys-217 interacts with the O8 of extrahelical 8-oxoguanine . This recognition process involves both direct interactions with the damaged base and assessment of DNA helix distortion caused by the damage. Additionally, Arg-108 provides specificity for bases positioned opposite the lesion, influencing the enzyme's substrate discrimination capabilities .

What are the key structural features of mutM that determine its substrate specificity?

Several key structural features determine mutM's substrate specificity:

  • Binding Pocket Residues: Lys-217 specifically interacts with the O8 of 8-oxoguanine, helping determine specificity for this oxidatively damaged base .

  • Reading Head Components: His-89 and Arg-109 form part of the structural element used to scan DNA for damage, with His-89 playing a role in determining specificity for oxidatively damaged bases .

  • Opposite-Base Recognition: Arg-108 forms hydrogen bonds with cytosine in the mutM-DNA complex, serving as a major determinant of opposite-base specificity .

  • Base-Flipping Mechanism: The enzyme employs a base-flipping mechanism to extrude damaged nucleotides from the DNA helix for examination and processing.

These structural elements work in concert to enable mutM to distinguish between normal and damaged DNA bases, as well as between different types of DNA lesions.

How do specific amino acid mutations affect mutM's catalytic activity and substrate discrimination?

Specific amino acid mutations in mutM can significantly alter its catalytic activity and substrate discrimination capabilities in distinct ways:

These mutation studies reveal the specific roles of individual amino acid residues in the catalytic mechanism and substrate recognition process of mutM. The differential effects of these mutations provide insight into how the enzyme achieves selectivity for particular DNA lesions while maintaining efficiency in repair processes.

What are the current challenges in producing active recombinant mutM for research applications?

Producing active recombinant mutM presents several challenges that researchers must address:

  • Protein Folding and Solubility: Recombinant mutM often forms inclusion bodies during bacterial expression, requiring optimization of expression conditions (temperature, induction parameters) and solubilization strategies.

  • Post-translational Modifications: Ensuring proper folding and incorporation of any required post-translational modifications that may affect enzymatic activity.

  • Metal Ion Coordination: MutM contains a zinc finger domain requiring proper metal coordination for structural integrity and function. Expression systems must provide appropriate conditions for metal incorporation.

  • Stability During Purification: Maintaining enzymatic activity throughout multi-step purification protocols, which may require buffer optimization and stabilizing additives.

  • Quality Control Assessment: Developing reliable assays to verify that the recombinant protein maintains native substrate specificity and catalytic efficiency.

Addressing these challenges requires experimental design optimization, including selection of appropriate expression vectors, host systems, and purification strategies based on true experimental research design principles .

How do the kinetic parameters of mutM vary across different oxidative DNA lesions?

The kinetic parameters of mutM vary significantly across different oxidative DNA lesions, reflecting its evolved substrate preferences:

DNA LesionRelative Excision RateKm Value (μM)kcat Value (min⁻¹)Context Dependencies
8-oxoguanineHigh (reference)LowHighAffected by opposite base (C>A>G>T)
FapyGModerate to HighMediumMediumLess affected by opposite base
FapyALow to ModerateHighLowRequires specific sequence context
5-hydroxyuracilVery LowVery HighVery LowLimited excision activity
DihydrouracilModerateMediumMediumUsed as non-specific control

These variations in kinetic parameters demonstrate the substrate discrimination capabilities of mutM, which have evolved to prioritize repair of the most mutagenic lesions. Understanding these parameters is essential for designing appropriate enzyme assays and interpreting experimental results when studying the biochemical properties of recombinant mutM.

What are the optimal expression systems for producing functional recombinant mutM?

When selecting an expression system for producing functional recombinant mutM, researchers should consider several factors that influence yield and activity:

  • Bacterial Expression Systems:

    • E. coli BL21(DE3): Often preferred for its reduced protease activity and compatibility with T7 promoter-based expression vectors.

    • E. coli Rosetta or Origami strains: Beneficial when codon usage or disulfide bond formation are limiting factors.

  • Expression Vector Selection:

    • Vectors with tightly controlled inducible promoters help minimize toxicity.

    • Fusion tags (His, GST, MBP) can enhance solubility and facilitate purification, though their impact on activity must be assessed.

  • Expression Conditions:

    • Lower temperatures (16-25°C) often improve proper folding.

    • Induction at lower IPTG concentrations (0.1-0.5 mM) and mid-log phase (OD600 = 0.6-0.8) typically yields better results.

    • Addition of zinc in culture media may improve proper folding of the zinc finger domain.

  • Purification Strategy:

    • Multi-step purification combining affinity chromatography with ion exchange and size exclusion.

    • Buffer optimization to maintain enzyme stability throughout purification.

This approach to expression system selection follows true experimental research design principles, allowing for controlled variable manipulation while maintaining consistent conditions for the experimental group .

How can researchers effectively design site-directed mutagenesis experiments to study mutM function?

Designing effective site-directed mutagenesis experiments for mutM requires a systematic approach:

  • Target Selection Based on Structural Data:

    • Prioritize residues identified through molecular dynamics and bioinformatics approaches as likely involved in substrate recognition or catalysis .

    • Consider conserved residues across species (His-89, Arg-108, Arg-109) that may have functional significance .

    • Target residues that directly interact with DNA or the damaged base (e.g., Lys-217 interaction with O8 of 8-oxoguanine) .

  • Mutation Type Selection:

    • Conservative substitutions: Maintain charge/size properties to assess subtle functional contributions.

    • Non-conservative substitutions: Dramatically alter properties to confirm essential roles.

    • Alanine scanning: Systematically replace residues with alanine to identify critical regions.

  • Control Design:

    • Include wild-type enzyme as positive control.

    • Use enzymatically inactive mutant (catalytic residue mutation) as negative control.

    • Include non-specific substrate controls (e.g., dihydrouracil) to distinguish specific from general effects .

  • Experimental Validation:

    • Combine DNA binding assays with catalytic activity measurements.

    • Assess activity against multiple substrates to detect selectivity changes.

    • Evaluate kinetic parameters (Km, kcat) to quantify effects on substrate discrimination.

This approach follows quasi-experimental research design principles, where variables are manipulated but complete randomization may not be possible .

What are the most reliable assays for measuring mutM activity in vitro?

Several complementary assays provide reliable measurement of mutM activity in vitro:

  • Gel-Based DNA Glycosylase Assays:

    • Principle: Measures cleavage of oligonucleotide substrates containing specific lesions.

    • Methodology: Synthetic oligonucleotides containing site-specific lesions (e.g., 8-oxoguanine) are incubated with mutM, and reaction products are separated on denaturing polyacrylamide gels.

    • Advantages: Allows direct visualization of substrate and product; accommodates various substrates and conditions.

    • Limitations: Semi-quantitative; requires radioisotopic or fluorescent labeling.

  • Fluorescence-Based Real-Time Assays:

    • Principle: Uses molecular beacons or FRET-based substrates to detect glycosylase activity in real-time.

    • Methodology: Fluorescence signal changes upon enzymatic processing of the substrate.

    • Advantages: Continuous monitoring; high-throughput compatible; no post-reaction processing.

    • Limitations: Substrate design constraints; potential fluorophore interference with enzyme activity.

  • Mass Spectrometry-Based Assays:

    • Principle: Directly measures mass changes resulting from base excision.

    • Methodology: MALDI-TOF or LC-MS analysis of reaction products.

    • Advantages: High accuracy; no labeling required; detects unexpected reaction products.

    • Limitations: Lower throughput; requires specialized equipment.

  • DNA Binding Assays:

    • Principle: Measures enzyme-substrate complex formation separate from catalysis.

    • Methodology: Electrophoretic mobility shift assays (EMSA) or fluorescence anisotropy.

    • Advantages: Distinguishes binding defects from catalytic defects; provides Kd values.

    • Limitations: May not reflect catalytic competence of complexes.

The selection of appropriate assays should be guided by true experimental research design principles, ensuring proper controls and variable isolation .

How should researchers interpret apparent discrepancies in mutM activity across different experimental systems?

When facing discrepancies in mutM activity across experimental systems, researchers should employ a systematic analytical approach:

  • Identify System Variables:

    • Enzyme Source and Purity: Recombinant versus native enzyme; presence of contaminating activities; tag interference.

    • Substrate Differences: Oligonucleotide length; sequence context; lesion positioning; single- versus double-stranded DNA.

    • Reaction Conditions: pH; salt concentration; metal ion availability; reducing agents; temperature.

    • Detection Methods: Direct versus indirect measures; sensitivity differences; dynamic range limitations.

  • Comparative Analysis Framework:

    • Normalize data using internal standards when comparing across systems.

    • Establish relative rather than absolute activity measurements where appropriate.

    • Calculate fold-changes rather than comparing raw values from different detection methods.

  • Statistical Evaluation:

    • Apply appropriate statistical tests to determine if differences are significant.

    • Consider variance components analysis to identify major sources of variability.

    • Implement multivariate analysis when multiple factors may contribute to observed differences.

  • Reconciliation Strategies:

    • Conduct side-by-side comparisons under standardized conditions.

    • Design experiments to isolate and test specific variables suspected of causing discrepancies.

    • Consider whether discrepancies reveal biologically relevant insights about context-dependent enzyme function.

This analytical framework applies quasi-experimental research design principles to systematically evaluate variables that may not have been initially randomized or controlled .

What computational approaches can enhance the analysis of mutM structure-function relationships?

Computational approaches provide powerful tools for analyzing mutM structure-function relationships:

  • Molecular Dynamics Simulations:

    • Application: Simulate enzyme-substrate interactions over time to identify transient interactions not visible in static structures .

    • Methodology: All-atom simulations in explicit solvent using AMBER, CHARMM, or GROMACS force fields.

    • Output Analysis: Trajectory analysis for hydrogen bonding patterns, conformational changes, and water-mediated interactions.

    • Advantages: Reveals dynamic aspects of enzyme function; predicts effects of mutations; identifies allosteric networks.

  • Bioinformatics Approaches:

    • Sequence Conservation Analysis: Identifies evolutionarily conserved residues likely to have functional importance .

    • Homology Modeling: Constructs structural models based on related proteins when experimental structures are unavailable.

    • Phylogenetic Analysis: Traces evolutionary relationships and functional divergence patterns.

    • Database Mining: Extracts patterns from structural databases to identify common structural motifs in glycosylases.

  • Quantum Mechanics/Molecular Mechanics (QM/MM):

    • Application: Models electronic structure during catalysis to understand reaction mechanisms.

    • Methodology: Combined quantum mechanical treatment of active site with molecular mechanical treatment of protein environment.

    • Output: Energy profiles along reaction coordinate; transition state structures; reaction rate predictions.

  • Machine Learning Approaches:

    • Substrate Specificity Prediction: Trains models on known substrate preferences to predict activity on novel lesions.

    • Structure-Activity Relationship: Correlates structural features with experimental activity data.

    • Feature Extraction: Identifies structural and sequence patterns associated with particular functional properties.

These computational methods complement experimental approaches by generating testable hypotheses and providing mechanistic insights not directly observable through experiments alone .

How can researchers overcome common challenges in purifying active recombinant mutM?

Purifying active recombinant mutM presents several challenges that can be addressed through specific troubleshooting approaches:

  • Inclusion Body Formation:

    • Challenge: Recombinant mutM often aggregates into insoluble inclusion bodies.

    • Solutions:

      • Lower expression temperature to 16-18°C.

      • Reduce inducer concentration and extend induction time.

      • Co-express with chaperone proteins (GroEL/GroES, DnaK/DnaJ).

      • Add solubility-enhancing fusion tags (MBP, SUMO, TRX).

      • Use lysis buffers containing mild detergents (0.1% Triton X-100).

  • Loss of Activity During Purification:

    • Challenge: Enzyme activity diminishes through purification steps.

    • Solutions:

      • Add stabilizing agents (glycerol 10-20%, DTT 1-5 mM).

      • Include zinc or other required metal ions in buffers.

      • Maintain constant low temperature during purification.

      • Minimize exposure to air/oxidation.

      • Reduce purification steps and processing time.

  • Zinc Finger Domain Integrity:

    • Challenge: Maintaining intact zinc finger domain essential for DNA binding.

    • Solutions:

      • Include ZnCl₂ (10-50 μM) in all buffers.

      • Add reducing agents to prevent cysteine oxidation.

      • Avoid strong chelating agents (EDTA) in buffers.

      • Verify zinc content using colorimetric assays (PAR assay).

  • Removal of Nucleic Acid Contamination:

    • Challenge: DNA/RNA co-purification interferes with activity assays.

    • Solutions:

      • High salt washes (0.5-1.0 M NaCl) during affinity purification.

      • Treatment with nucleases (Benzonase) followed by additional purification.

      • Polyethyleneimine precipitation step.

      • Anion exchange chromatography under conditions that separate protein from nucleic acids.

These troubleshooting approaches follow pre-experimental research design principles by identifying key variables that affect enzyme quality before proceeding to main experiments .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.